NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Lotus Technology Inc. ("Lotus" or the "Company") (Nasdaq: LOT), a leading global intelligent and luxury mobility provider, today announced that it will report its unaudited financial results for the first quarter 2025 on June 25, 2025, before market opening in the United States. The Company’s management will host an earnings conference call at 8:00 AM U.S. Eastern Time on Wednesday, June 25, 2025 (14:00 Central European Time / 20:00 China Standard Time on the same ...

June 16, 2025 04:01 AM GMT Telecom & Networking Equipment | North America M Foundation Next-Gen Optical Technologies: OCS, CPO and LPO, Oh My As power and reliability needs grow, advanced AI networks will eventually demand next-gen optical technologies. These technologies solve for different problems, but all have unique challenges to implementation. Continue to see linear adoption before CPO or OCS, though monitoring OCS adoption. Key Takeaways No easy solutions, but lots of hard ones. The $8bn optical tra ...

Key Takeaways CLS expects 2025 sales to rise 13.1% and EPS to grow 30.1% with strong demand for AI-driven data solutions. Flex sees 50% growth in cloud/data center power and anticipates continued strength into fiscal 2026. FLEX trades at a lower forward P/E of 14.49 versus CLS at 22.72, making it more attractive on valuation.Celestica Inc. (CLS) and Flex Ltd. (FLEX) are two leading players in the electronics manufacturing services (EMS) industry. Celestica is one of the largest EMS companies in the world, ...

BEIJING, June 16, 2025 /PRNewswire/ -- Cheetah Mobile Inc. ("Cheetah Mobile" or the "Company") (NYSE: CMCM), a China-based IT company, today announced that it will report its financial results for the first quarter 2025 before the U.S. market opens on Thursday, June 19, 2025.The earnings release will be available on the Company's investor relations website at http://ir.cmcm.com. Cheetah Mobile's management will hold an earnings conference call at 8:00 AM on Thursday, June 19, 2025, U.S. Eastern Time (8:00 P ...

Group 1 - Ouster, a small-cap tech company, experienced a 27% increase in share price following the U.S. Department of Defense's approval of its digital lidar sensor for unmanned aerial systems [1][5][6] - The company specializes in digital lidar sensors, which utilize lasers for distance measurement, creating 3D maps for various applications [2][3] - Ouster's total addressable market is estimated at $70 billion, despite generating only $118 million in revenue over the past 12 months [4] Group 2 - The OS1 sensor, approved by the DoD, is the first high-resolution 3D lidar sensor to receive Blue UAS approval, facilitating easier procurement for defense entities [7][6] - Ouster's Digital Flash (DF) Series, currently in development, aims to meet the needs of advanced driver assistance systems and autonomous driving, featuring a solid-state design for improved reliability [8][9] - Analysts have downgraded Ouster's stock from Overweight to Neutral, with a price target of $19, indicating a potential downside despite the recent positive news [10][11] Group 3 - Ouster's adjusted operating income is approximately -$85 million, with free cash flow at -$36 million, but the company has $168 million in cash and short-term investments to sustain operations [11] - The company's share price has surged nearly 150% over the past three months, reflecting strong market interest [11]

Core Insights - Caterpillar Inc. and Volvo are leading companies in the heavy machinery and construction equipment industry, focusing on electrification and autonomous technologies to drive future growth [1][2]. Caterpillar Overview - Caterpillar has a market capitalization of $171 billion and is the world's leading manufacturer of construction and mining equipment, operating through three segments: Construction Industries, Resource Industries, and Energy & Transportation [2][3]. - The company has experienced six consecutive quarters of volume declines, with revenues dropping 3.4% in fiscal 2024 and 9.8% in Q1 2025, primarily due to weak demand in the Resource and Construction Industries [4][5]. - Despite challenges, Caterpillar is expected to benefit from the U.S. Infrastructure Investment and Jobs Act, which will drive demand for mining equipment and autonomous fleet solutions [7][8]. Volvo Overview - Volvo, with a market capitalization of $16.2 billion, manufactures trucks, buses, and construction equipment, with its subsidiary Volvo Construction Equipment producing a wide range of machinery [2][9]. - Volvo CE's net sales decreased by 16% in fiscal 2024 and 8% in Q1 2025, impacted by high interest rates and low confidence in Europe and North America [11][12]. - The company is focusing on innovation, launching over 80 new models in 2024, including electric machines, to position itself for long-term growth [13][14]. Financial Performance and Estimates - The Zacks Consensus Estimate for Caterpillar's 2025 earnings is $18.70 per share, reflecting a year-over-year decline of 14.6%, while the estimate for 2026 indicates a rise of 12.8% [16]. - For Volvo, the fiscal 2025 earnings estimate is $2.24 per share, down 4.3% year-over-year, with a projected growth of 13.7% in 2026 [17]. - Year-to-date, Caterpillar's stock has dipped 0.5%, while Volvo's stock has gained 16.3%, outperforming the Industrial Products Sector and the S&P 500 [19]. Valuation and Performance Metrics - Caterpillar is trading at a forward 12-month earnings multiple of 18.26, while Volvo is at 11.8, both below the sector average [20]. - Caterpillar's return on equity stands at 53.77%, significantly higher than Volvo's 24.36%, indicating more efficient use of shareholder funds [21]. Investment Considerations - Both companies face near-term challenges but are well-positioned for long-term growth driven by global infrastructure needs [25]. - Caterpillar, despite a higher valuation, is considered a more favorable option for investors seeking exposure to construction equipment, holding a Zacks Rank 3 (Hold), while Volvo has a Zacks Rank 4 (Sell) [26].

Company Overview - Proactive is a financial news publisher that provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The company has a team of experienced and qualified news journalists who produce independent content [2] Market Focus - Proactive specializes in medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - The content includes insights across various sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Technology Adoption - Proactive is recognized for its forward-looking approach and enthusiastic adoption of technology to enhance workflows [4] - The company utilizes automation and software tools, including generative AI, while ensuring that all content is edited and authored by humans [5]

Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The news team covers medium and small-cap markets, as well as blue-chip companies, commodities, and broader investment stories [3] - Proactive has bureaus and studios in key finance and investing hubs including London, New York, Toronto, Vancouver, Sydney, and Perth [2] Group 2 - The company is focused on sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] - Proactive adopts technology to enhance workflows and improve content production [4] - Automation and software tools, including generative AI, are used, but all content is edited and authored by humans [5]

PRINCETON, N.J., June 13, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being developed for IV infusion to address significant unmet medical needs in aneurysmal subarachnoid hemorrhage (aSAH) patients, today announced that Chief Executive Officer Prashant Kohli will participate in the upcoming BIO 2025 International Conference, to be held in ...

Showcased 7 presentations at ISSCR 2025, including a featured oral presentation on first-in-human gene therapy for heart failure, powered by their proprietary human mini-Heart technology.FDA-backed human-based screening platform recognized as an animal-free alternative in drug development, supporting IND and Fast Track approvals under the FDA Modernization Act 2.0.Breakthroughs in high-throughput screening, AI-driven drug classification, and patient-specific disease modelling underscored the platform’s pote ...